Compliance Rate
Compliance Rate
0.0%
Compliant submissions
0
Incompliant submissions
1
Total trials
1
My Organizations' Clinical Trials
Showing 1275 of 1294 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/05/22
End: 08/14/22
Due: 08/14/23
Phase: N/A
Priority: Normal
Start: 12/31/10
End: 10/31/18
Due: 10/31/19
Phase: N/A
Priority: Normal
Start: 01/10/22
End: 08/09/24
Due: 08/09/25
Phase: N/A
Priority: Normal
Start: 05/31/12
End: 07/31/15
Due: 07/31/16
Phase: N/A
Priority: Normal
Start: 02/28/07
End: 10/31/09
Due: 10/31/10
Phase: N/A
Priority: Normal
Start: 08/31/08
End: 01/31/12
Due: 01/31/13
Phase: N/A
Priority: Normal
Start: 05/26/21
End: 04/14/23
Due: 04/14/24
Phase: N/A
Priority: Normal
Start: 09/24/18
End: 08/15/20
Due: 08/15/21
Phase: N/A
Priority: Normal
Start: 06/15/25
End: 08/28/25
Due: 08/28/26
Phase: N/A
Priority: Normal
Start: 01/31/16
End: 12/21/16
Due: 12/21/17
Phase: N/A
Priority: Normal
Start: 08/02/23
End: 09/29/23
Due: 09/29/24
Phase: N/A
Priority: Normal
Start: 12/31/09
End: 08/31/10
Due: 08/31/11
Phase: N/A
Priority: Normal
Start: 04/30/08
End: 12/31/16
Due: 12/31/17
Phase: N/A
Priority: Normal
Start: 12/31/13
End: 04/30/15
Due: 04/30/16
Phase: N/A
Priority: Normal
Start: 12/12/24
End: 06/30/26
Due: 06/30/27
Phase: N/A
Priority: Normal
Start: 05/31/12
End: 07/31/14
Due: 07/31/15
Phase: N/A
Priority: Normal
Start: 03/31/16
End: 10/31/17
Due: 10/31/18
Phase: N/A
Priority: Normal
Start: 05/25/18
End: 04/24/20
Due: 04/24/21
Phase: N/A
Priority: Normal
Start: 05/31/25
End: 05/31/25
Due: 05/31/26
Phase: N/A
Priority: Normal
Start: 02/28/02
End: 05/31/07
Due: 05/31/08
Phase: N/A
Priority: Normal
Start: 05/09/19
End: 06/30/22
Due: 06/30/23
Changes in Renal Artery Movement Due to Respiration Before and After Fenestrated Endovascular Repair
Phase: N/A
Priority: Normal
Start: 08/31/15
End: 08/31/15
Due: 08/31/16
Phase: N/A
Priority: Normal
Start: 05/31/15
End: 09/30/20
Due: 09/30/21
Phase: N/A
Priority: Normal
Start: 04/30/14
End: 01/31/16
Due: 01/31/17
Phase: N/A
Priority: Normal
Start: 09/15/24
End: 03/31/28
Due: 03/31/29